Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1

4(57.1%)

Phase 4

2(28.6%)

N/A

1(14.3%)

7Total

Phase 1(4)

Phase 4(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06568900Not ApplicableCompleted

Randomized Controlled Trial to Evaluate the Impact of ZYN Nicotine Pouch Products on Cigarette Usage and BoExp in Adult Smokers Over a 12-week Period

Role: lead

NCT00843622Phase 4Completed

Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette Smokers

Role: lead

NCT00601042Phase 4Completed

Serbian Smoking Reduction/Cessation Trial (2SRT)

Role: lead

NCT01838473Phase 1Completed

In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Swedish 'Snus' in Regular Snus Users

Role: collaborator

NCT01369693Phase 1Completed

In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus

Role: collaborator

NCT01249339Phase 1Completed

In-vivo Extraction of Pb, Cd andTSNA From Swedish Snus

Role: collaborator

NCT01182129Phase 1Completed

4 mg Nicotine Polacrilex Gum and Swedish Portion Snus

Role: collaborator

All 7 trials loaded